Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lonch Group is a comprehensive healthcare conglomerate based in Shanghai, China, operating across the medical device, pharmaceutical, and biotechnology sectors. The company functions as an integrated platform that combines research and development, manufacturing, and a robust distribution network to serve the Chinese healthcare market. Through its subsidiary, Lonch (Beijing) Biopharmaceutical, the group focuses on advanced drug delivery systems, particularly liposomal formulations for oncology and cardiovascular applications. Additionally, Lonch Group is a significant player in the medical equipment sector, providing both proprietary products and acting as a strategic partner for international medical brands. The company aims to provide holistic health solutions ranging from early-stage R&D to clinical application and health management services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lonch Group.